Gene · 200424
Papers2,594
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,594
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins. | Int J Mol Sci | 2023 | 38003566 | PubTator, text mining | PubMed |
| In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). | Int J Mol Sci | 2023 | 38003223 | PubTator, text mining | PubMed |
| The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas. | Curr Issues Mol Biol | 2023 | 37998740 | PubTator, text mining | PubMed |
| Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL. | J Hematol Oncol | 2023 | 37993905 | PubTator, text mining | PubMed |
| Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype. | Sci Adv | 2023 | 37992163 | PubTator, text mining | PubMed |
| Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids. | Diseases | 2023 | 37987267 | PubTator, text mining | PubMed |
| Insights into the regulatory role of RNA methylation modifications in glioma. | J Transl Med | 2023 | 37964279 | PubTator, text mining | PubMed |
| Racial disparities between measures of area deprivation and financial toxicity, and uterine volume in myomectomy patients. | BMC Womens Health | 2023 | 37964227 | PubTator, text mining | PubMed |
| Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo. | Cell Rep Methods | 2023 | 37949066 | PubTator, text mining | PubMed |
| Case Series of Hepatosplenic T-Cell Lymphoma: A Rare and Aggressive Disease. | Case Rep Oncol | 2023 | 37933311 | PubTator, text mining | PubMed |
| Upregulation of RSPO3 via targeted promoter DNA demethylation inhibits the progression of cholangiocarcinoma. | Clin Epigenetics | 2023 | 37932819 | PubTator, text mining | PubMed |
| Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma. | Front Oncol | 2023 | 37916165 | PubTator, text mining | PubMed |
| Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma. | Sci Rep | 2023 | 37907576 | PubTator, text mining | PubMed |
| Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review. | Medicine (Baltimore) | 2023 | 37904441 | PubTator, text mining | PubMed |
| Let-7 suppresses liver fibrosis by inhibiting hepatocyte apoptosis and TGF-β production. | Mol Metab | 2023 | 37898449 | PubTator, text mining | PubMed |
| Effect of Long-Term Low-Dose Arsenic Exposure on DNA Methylation and Gene Expression in Human Liver Cells. | Int J Mol Sci | 2023 | 37894918 | PubTator, text mining | PubMed |
| Panoramic on Epigenetics in Coronary Artery Disease and the Approach of Personalized Medicine. | Biomedicines | 2023 | 37893238 | PubTator, text mining | PubMed |
| Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms. | BMC Cancer | 2023 | 37884893 | PubTator, text mining | PubMed |
| Meta-analysis of genome-wide association studies of gestational duration and spontaneous preterm birth identifies new maternal risk loci. | PLoS Genet | 2023 | 37871108 | PubTator, text mining | PubMed |
| Biological insights into the role of TET2 in T cell lymphomas. | Front Oncol | 2023 | 37841428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200424/papers?page=12